scholarly article | Q13442814 |
P50 | author | J. Silvio Gutkind | Q52088940 |
Lalage M Wakefield | Q57066490 | ||
P2093 | author name string | Ashok B Kulkarni | |
Juan Du | |||
Alfredo Molinolo | |||
Pin Zhang | |||
Wanjun Chen | |||
Kathleen C Flanders | |||
Anita Terse | |||
Bradford Hall | |||
Yansong Bian | |||
P2860 | cites work | Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity | Q24297858 |
Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis | Q24679619 | ||
Cancer statistics, 2008 | Q27860585 | ||
PTEN: one gene, many syndromes | Q28203387 | ||
Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 | ||
TGFbeta in Cancer | Q28288866 | ||
Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice | Q28361871 | ||
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion | Q29547317 | ||
Specificity and versatility in tgf-beta signaling through Smads | Q29616324 | ||
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia | Q29618875 | ||
Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia | Q30482281 | ||
Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma. | Q30858776 | ||
Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis | Q33868837 | ||
Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis | Q34414642 | ||
Somatic acquisition and signaling of TGFBR1*6A in cancer | Q34456847 | ||
The logic of TGFbeta signaling. | Q34522372 | ||
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma | Q34653637 | ||
Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment | Q34761564 | ||
Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression | Q35127700 | ||
The two faces of transforming growth factor beta in carcinogenesis | Q35170231 | ||
Role of tissue stroma in cancer cell invasion | Q35170428 | ||
The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin | Q35555290 | ||
Focus on head and neck cancer | Q35749406 | ||
Molecular pathology of head-and-neck cancer | Q35894529 | ||
TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. | Q36001319 | ||
Alterations in components of the TGF-beta superfamily signaling pathways in human cancer | Q36323395 | ||
Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity | Q36490747 | ||
Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer | Q36516410 | ||
Dysregulated molecular networks in head and neck carcinogenesis | Q37274623 | ||
Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells | Q38806280 | ||
Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors | Q39646992 | ||
Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth | Q39939459 | ||
TGF-beta receptor I conditional knockout mice develop spontaneous squamous cell carcinoma. | Q40126839 | ||
Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. | Q40316439 | ||
Attenuated type II TGF-beta receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination | Q40569154 | ||
Oral mucosal carcinogenesis in SENCAR mice. | Q40610345 | ||
Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers. | Q43686111 | ||
Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases | Q43690863 | ||
Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer | Q45345242 | ||
Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model | Q46166101 | ||
Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation | Q47255124 | ||
Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells | Q47735652 | ||
Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis. | Q52552644 | ||
Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. | Q54462818 | ||
Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis | Q77926084 | ||
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer | Q77948466 | ||
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer | Q78035700 | ||
A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells | Q81157115 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5918-5926 | |
P577 | publication date | 2009-07-07 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway | |
P478 | volume | 69 |
Q88312688 | Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma |
Q39627356 | B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma |
Q33771631 | Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma |
Q91620382 | CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling |
Q36295853 | Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. |
Q37709902 | Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma. |
Q34156955 | Comparative analysis of algorithms for integration of copy number and expression data |
Q91737735 | DNA-PKcs Mediates An Epithelial-Mesenchymal Transition Process Promoting Cutaneous Squamous Cell Carcinoma Invasion And Metastasis By Targeting The TGF-β1/Smad Signaling Pathway |
Q37044614 | Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression |
Q45990393 | Differential response of epithelial stem cell populations in hair follicles to TGF-β signaling. |
Q36346978 | Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma |
Q36539734 | ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas |
Q28543724 | Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma |
Q35035034 | Follistatin is induced by ionizing radiation and potentially predictive of radiosensitivity in radiation-induced fibrosis patient derived fibroblasts |
Q36405966 | High KIF2A expression predicts unfavorable prognosis in diffuse large B cell lymphoma |
Q36998335 | Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma |
Q37215789 | Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model |
Q35499428 | Inhibition of survivin reduces HIF-1α, TGF-β1 and TFE3 in salivary adenoid cystic carcinoma |
Q88636947 | Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer |
Q54979905 | Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin. |
Q38609786 | Keratoacanthoma: a distinct entity? |
Q38755849 | Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway |
Q41997200 | LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma. |
Q26800264 | Linking diet to acne metabolomics, inflammation, and comedogenesis: an update |
Q35722714 | Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. |
Q35879907 | Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor |
Q36863089 | MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma |
Q55554558 | Microbiota, Epithelium, Inflammation, and TGF-β Signaling: An Intricate Interaction in Oncogenesis. |
Q26749842 | Milk: a postnatal imprinting system stabilizing FoxP3 expression and regulatory T cell differentiation |
Q38337029 | Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. |
Q36561681 | PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma |
Q37025086 | PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer |
Q47329309 | Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma |
Q93050634 | Pathogenic effect of a TGFBR1 mutation in a family with Loeys-Dietz syndrome |
Q37785576 | Pathophysiology of oral cancer in experimental animal models: a review with focus on the role of sympathetic nerves |
Q35053451 | Pharmacologic inhibition of ALK5 causes selective induction of terminal differentiation in mouse keratinocytes expressing oncogenic HRAS. |
Q36653584 | Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer |
Q41948037 | Relationship between human oral lichen planus and oral squamous cell carcinoma at a genomic level: a datamining study |
Q37885217 | Role of Smads in TGFβ signaling |
Q34902060 | Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer |
Q34994908 | Simultaneous activation of Kras and inactivation of p53 induces soft tissue sarcoma and bladder urothelial hyperplasia |
Q33596982 | Smad4-mediated TGF-beta signaling in tumorigenesis |
Q36210115 | TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers |
Q37777022 | TGFβ signaling in head and neck squamous cell carcinoma |
Q34999356 | TGFβ signaling inhibits goblet cell differentiation via SPDEF in conjunctival epithelium. |
Q36964131 | Targeting TGF-β1 inhibits invasion of anaplastic thyroid carcinoma cell through SMAD2-dependent S100A4-MMP-2/9 signalling |
Q36522719 | The Role of TGFβ Signaling in Squamous Cell Cancer: Lessons from Mouse Models |
Q43134768 | Transforming Growth Factor Beta Signaling in Cutaneous Wound Healing: Lessons Learned from Animal Studies |
Q58767650 | Transforming growth factor-β signaling in head and neck squamous cell carcinoma: Insights into cellular responses |
Q92312818 | Tumor Suppressive Function of NQO1 in Cutaneous Squamous Cell Carcinoma (SCC) Cells |
Q34363852 | Use of a TGFβ type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFβ signaling in tumor promotion and progression |
Q34349271 | YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets. |
Search more.